Keller, Magdalena
Rohlf, Katharina
Glotzbach, Annika
Leonhardt, Gregor
Lüke, Simon
Derksen, Katharina
Demirci, Özlem
Göçener, Defne
AlWahsh, Mohammad
Lambert, Jörg
Lindskog, Cecilia
Schmidt, Marcus
Brenner, Walburgis
Baumann, Matthias
Zent, Eldar
Zischinsky, Mia-Lisa
Hellwig, Birte
Madjar, Katrin
Rahnenführer, Jörg
Overbeck, Nina
Reinders, Jörg
Cadenas, Cristina
Hengstler, Jan G.
Edlund, Karolina
Marchan, Rosemarie http://orcid.org/0000-0003-4414-1633
Funding for this research was provided by:
Deutsche Krebshilfe (70114035)
Deutsche Forschungsgemeinschaft (HE2509/10)
Knut och Alice Wallenbergs Stiftelse
Leibniz-Institut für Arbeitsforschung (IfADo)
Article History
Received: 8 June 2022
Accepted: 20 December 2022
First Online: 20 January 2023
Declarations
:
: The Research Ethics Committee at the University Medical Center Mainz approved the study in which the breast cancer tissue samples used to prepare the TMA were collected, and all patients provided informed consent. All animal studies were performed in accordance with the guidelines stipulated by the Society of Laboratory Animal Science (81–02.04.2020.A261, Gesellschaft für Versuchstierkunde, GV-SOLAS).
: Not applicable.
: Marcus Schmidt reported receiving grants or contracts, as well as consulting fees from AstraZeneca, BioNTech, Eisai, Novartis, Pantarhei Bioscience, Pfizer, Pierre Fabre, and Roche in the past 36 months. He also received grants from the German Breast Group and Genentech and consulting fees from Daiichi Sankyo, Lilly, MSD, and SeaGen. He is on the Data Safety Monitoring or Advisory Board of all of the above-listed organizations, with the exception of Genetech and MSD. Both Pfizer and Roche supported Prof. Schmidt’s travel to meetings and financially compensated him for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events along with AstraZeneca, Norvatis, and SeaGen. He has ownership interests (including patents) in EP 2951317 B1 and EP 2390370 B1. He declares no conflicts of interest regarding the data in the present manuscript. The other authors declare no competing financial interest.